Buscar
Haemonetics Corp
HAEAñadir a la lista de seguimiento
106.820USD
-1.700-1.57%
Cierre 09-22 16:00（ET）
4.85BCap. mercado
51.79P/E TTM
Fuera de horario 16:10 (ET)106.820USD-0.225-0.21%
Fuera de horario 16:10 (ET)Acerca de Haemonetics Corp Compañía
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Perfil de Haemonetics Corp
Símbolo de cotizaciónHAE
Nombre de la empresaHaemonetics Corp
Fecha de salida a bolsaOct 17, 1979
Director ejecutivoSimon (Christopher A)
Número de empleados3023
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 17
Dirección125 Summer Street
CiudadBOSTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal02110
Teléfono17818487100
Sitio Webhttps://www.haemonetics.com
Símbolo de cotizaciónHAE
Fecha de salida a bolsaOct 17, 1979
Director ejecutivoSimon (Christopher A)
Ejecutivos de Haemonetics Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
40.07K
-0.78%
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
40.07K
-0.78%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
34.51K
+10.58%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
34.51K
+10.58%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
27.52K
+9.22%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
27.52K
+9.22%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
25.89K
+9.80%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
25.89K
+9.80%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
21.91K
+11.58%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
40.07K
-0.78%
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
40.07K
-0.78%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
34.51K
+10.58%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
34.51K
+10.58%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
27.52K
+9.22%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
27.52K
+9.22%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Haemonetics Corp?
Los cinco principales accionistas de Haemonetics Corp son: Ms. Laurie A. Miller
¿Cuántas instituciones poseen acciones de Haemonetics Corp (HAE)?
A fecha de 2026Q1, 737 instituciones poseen acciones de Haemonetics Corp, con un valor de mercado combinado de aproximadamente 58.91M, lo que representa el 126.77% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 664078.00.